Congestive Heart Failure Drugs Market is expected to surpass US $13.8 billion by the year 2027, from US $ 6 billion in 2020.

In a recent research report by Maximize Market Research, the Congestive Heart Failure Drugs Market is expected to surpass US $13.8 billion by the year 2027, from US $ 6 billion in 2020. Despite a huge decline in the sales of products during the initial phase of pandemic spread and lockdown restrictions all over the […]

Global Oral Solid Dosage Pharmaceutical Formulation Market is expected to surpass the US $ 8.5 Billion by the year 2027, from the US $ 6.3 Billion in 2020.

Oral solid dosage Dosage Forms include tablets, capsules, soft gels, effervescence, gummies, pills and are all examples of small molecules. These oral solid dosage (OSD) Dosage Forms are swallowed through the mouth, dissolved in the digestive system and are passed through first pass metabolism via liver and supplied to the body via bloodstream absorption. Oral […]

Global Oxytocic Pharmaceuticals Market is expected to surpass US$ 4.3 Billion by the year 2027, from US$ 3.25 Billion in 2020.

Oxytocin, also known as the “love hormone,” is a female reproductive hormone that is created in the hypothalamus and released into the circulation during childbirth. In a nursing mother, this hormone stimulates labor and milk production. Oxytocic medications can be used as a uterotonic to help induce labor and prevent hemorrhage after a C-section. Aside […]

Global Genital Herpes Treatment Market is expected to surpass US$ 6.70 Billion by the year 2027, from US$ 4.99 Billion in 2020.

Herpes simplex virus induces genital herpes, which is a sexually transmitted infection. Symptoms of genital herpes include blisters on or around the genitals, vaginal discharge, pelvic pain, and penile discharge. As per the WHO in December 2015, around 1 million sexually transmitted infections are acquired every day around the world. According to the WHO, around 15% […]

Advanced Parenteral Drug Market is expected to surpass US$ 4.3 Billion by the year 2027, from US$ 3.25 Billion in 2020.

In the field of parenteral drug delivery, a number of technological advancements have led to the creation of complex systems that allow drug targeting and the sustained or regulated release of parenteral medicines. Parenteral formulations, especially intravascular formulations, provide a unique opportunity for direct access to the bloodstream, early commencement of drug activity, and targeting […]